Valeria Szijarto

Vienna, 1030, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Editorial: Innovative biologics in the battle against bacterial pathogens: disrupting pathogenesis with precision.

Editorial: Innovative biologics in the battle against bacterial pathogens: disrupting pathogenesis with precision.

Journal: Frontiers in microbiology
Published: August 03, 2026

Antiviral Potential of Azelastine against Major Respiratory Viruses.

Antiviral Potential of Azelastine against Major Respiratory Viruses.

Journal: Viruses
Published: October 25, 2023

Anti-Toxin Responses to Natural Enterotoxigenic Escherichia coli (ETEC) Infection in Adults and Children in Bangladesh.

Anti-Toxin Responses to Natural Enterotoxigenic Escherichia coli (ETEC) Infection in Adults and Children in Bangladesh.

Journal: Microorganisms
Published: August 29, 2023

Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients.

Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients.

Journal: Scientific reports
Published: July 25, 2022

The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.

The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.

Journal: Frontiers in pharmacology
Published: January 24, 2022

Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial.

Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial.

Journal: Vaccines
Published: January 01, 2022

Characterization of ShigETEC, a Novel Live Attenuated Combined Vaccine against Shigellae and ETEC.

Characterization of ShigETEC, a Novel Live Attenuated Combined Vaccine against Shigellae and ETEC.

Journal: Vaccines
Published: October 15, 2020

The Impact of Insertion Sequences on O-Serotype Phenotype and Its O-Locus-Based Prediction in Klebsiella pneumoniae O2 and O1.

The Impact of Insertion Sequences on O-Serotype Phenotype and Its O-Locus-Based Prediction in Klebsiella pneumoniae O2 and O1.

Journal: International journal of molecular sciences
Published: August 22, 2020

The utility of endotracheal aspirate bacteriology in identifying mechanically ventilated patients at risk for ventilator associated pneumonia: a single-center prospective observational study.

The utility of endotracheal aspirate bacteriology in identifying mechanically ventilated patients at risk for ventilator associated pneumonia: a single-center prospective observational study.

Journal: BMC infectious diseases
Published: February 09, 2019

A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway.

A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway.

Journal: Frontiers in immunology
Published: June 23, 2018

Directly Bactericidal Anti-Escherichia coli Antibody.

Directly Bactericidal Anti-Escherichia coli Antibody.

Journal: Trends in microbiology
Published: May 18, 2018

Complete Genome Sequence of Escherichia coli 81009, a Representative of the Sequence Type 131 C1-M27 Clade with a Multidrug-Resistant Phenotype.

Complete Genome Sequence of Escherichia coli 81009, a Representative of the Sequence Type 131 C1-M27 Clade with a Multidrug-Resistant Phenotype.

Journal: Genome announcements
Published: February 24, 2018
Showing 1-12 of 24

Last Updated: 09/26/2026